A method of matching nodes between MRI and pathology in rectal cancer patients
Author Block: Q-Y. Li, X-Y. Yan, D. Yang, Z. Guan, R-J. Sun, Q. Lu, L. X. Ting, X. Zhang, Y-S. Sun; Beijing/CN
Purpose: To develop a method that enables node-by-node matching between preoperative MRI and postoperative pathology in rectal cancer patients, thereby providing reliable node-based ground-truth labels for further radiological studies.
Methods or Background: This methodological study prospectively enrolled 535 patients (59 ± 11 years; 326 males) with rectal cancer between 2021 and 2023. Target nodes were defined as nodal structures with a short-axis diameter (SAD) of ≥ 3 mm in the mesorectum or around the superior rectal artery on MRI. With relative location to the tumor, rectal wall and mesorectal fascia, each target node was localized in three directions. Combining the coordinates of each node, a 3D node map centered on the tumor and including all target nodes was constructed for each patient and used as a bridge enabling node-by-node matching between MRI and pathology.
Results or Findings: 3,038 target nodes were detected on preoperative MRI, of which 2,220 (73.1%) achieved matched between MRI and pathology.
Of the 1,707 matched benign nodes, 1,321 (77.4%), 378 (22.1%), and 8 (0.5%) had SADs of <5 mm, 5-9 mm and >9 mm, respectively. Whereas of the 513 matched metastatic nodes, 224 (43.7%), 254 (49.5%), and 35 (6.8%) had SADs of <5 mm, 5-9 mm and >9 mm, respectively.
Patients with lower matching rates tended to have higher T-stages and more target nodes on MRI, whereas other factors, e.g. the BMI, therapeutic regimen, tumor location, and time interval between MRI and pathological examination did not show significant effect on the matching accuracy.
Conclusion: A matching method between MRI and pathology was developed to label numerous nodes with precise statuses in rectal cancer patients, which contributes to future radiological studies.
Limitations: The limitation is the small proportion of metastatic nodes compared to benign ones.
Funding for this study: Funding was received from the National Natural Science Foundation of China (82271955) and Capital's Funds for Health Improvement and Research (2024-1-1022).
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: This study was approved by the institutional review board (No. 2019KT76).